SI1377574T1 - - Google Patents
Info
- Publication number
- SI1377574T1 SI1377574T1 SI200230083T SI200230083T SI1377574T1 SI 1377574 T1 SI1377574 T1 SI 1377574T1 SI 200230083 T SI200230083 T SI 200230083T SI 200230083 T SI200230083 T SI 200230083T SI 1377574 T1 SI1377574 T1 SI 1377574T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pde3
- inhibitors
- compounds
- formula
- description
- Prior art date
Links
- 101100135868 Dictyostelium discoideum pde3 gene Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Electroluminescent Light Sources (AREA)
- Pyridine Compounds (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01104086 | 2001-02-21 | ||
| PCT/EP2002/001819 WO2002066476A1 (en) | 2001-02-21 | 2002-02-21 | 6-phenylbenzonaphthyridines |
| EP02722110A EP1377574B1 (en) | 2001-02-21 | 2002-02-21 | 6-phenylbenzonaphthyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1377574T1 true SI1377574T1 (OSRAM) | 2005-08-31 |
Family
ID=8176545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200230083T SI1377574T1 (OSRAM) | 2001-02-21 | 2002-02-21 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6936622B2 (OSRAM) |
| EP (1) | EP1377574B1 (OSRAM) |
| JP (1) | JP4248245B2 (OSRAM) |
| AT (1) | ATE287403T1 (OSRAM) |
| AU (1) | AU2002253045B2 (OSRAM) |
| CA (1) | CA2438717C (OSRAM) |
| DE (1) | DE60202669T2 (OSRAM) |
| DK (1) | DK1377574T3 (OSRAM) |
| ES (1) | ES2236504T3 (OSRAM) |
| PT (1) | PT1377574E (OSRAM) |
| SI (1) | SI1377574T1 (OSRAM) |
| WO (1) | WO2002066476A1 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003263216A1 (en) * | 2002-08-17 | 2004-03-11 | Nycomed Gmbh | Benzonaphthyridines with PDE 3/4 inhibiting activity |
| PL374014A1 (en) * | 2002-08-17 | 2005-09-19 | Altana Pharma Ag | Novel phenanthridines having pde 3/4 inhibiting properties |
| US7423046B2 (en) | 2002-08-29 | 2008-09-09 | Nycomed Gmbh | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| JP4638736B2 (ja) * | 2002-09-04 | 2011-02-23 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のベンゾナフチリジン |
| HRP20050293A2 (en) | 2002-09-04 | 2006-07-31 | Altana Pharma Ag | Novel benzonaphthyridines |
| WO2005077906A1 (en) | 2004-02-18 | 2005-08-25 | Altana Pharma Ag | Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| SG182194A1 (en) | 2004-03-03 | 2012-07-30 | Nycomed Gmbh | Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors |
| NZ549254A (en) * | 2004-03-10 | 2010-06-25 | Nycomed Gmbh | Amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors |
| US7671068B2 (en) | 2004-03-17 | 2010-03-02 | Nycomed Gmbh | N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors |
| SI1856093T1 (sl) | 2005-03-02 | 2010-03-31 | Nycomed Gmbh | Hidrokloridna sol R aR bR dimetoksipiridin il etoksi metoksi a b heksahidrofenantridin ola |
| WO2018069210A1 (en) | 2016-10-10 | 2018-04-19 | Takeda Gmbh | Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20012390B (en) * | 1996-11-11 | 2001-03-25 | Byk Gulden Lomberg Chem Fab | Benzonaphthyridines as Bronchial Therapeutics |
| US6143759A (en) * | 1997-03-07 | 2000-11-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrazoles |
| AU8106598A (en) * | 1997-06-03 | 1998-12-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
| SI1075477T1 (en) | 1998-05-05 | 2003-08-31 | Altana Pharma Ag | Novel Benzonaphthyridine-N-oxides |
| JP2002523505A (ja) | 1998-08-31 | 2002-07-30 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | Ｐｄｅ３−及びｐｄｅ−４抑制作用を有するベンゾナフチリデン−ｎ−オキシド |
-
2002
- 2002-02-21 CA CA2438717A patent/CA2438717C/en not_active Expired - Fee Related
- 2002-02-21 ES ES02722110T patent/ES2236504T3/es not_active Expired - Lifetime
- 2002-02-21 PT PT02722110T patent/PT1377574E/pt unknown
- 2002-02-21 WO PCT/EP2002/001819 patent/WO2002066476A1/en not_active Ceased
- 2002-02-21 DK DK02722110T patent/DK1377574T3/da active
- 2002-02-21 AU AU2002253045A patent/AU2002253045B2/en not_active Ceased
- 2002-02-21 EP EP02722110A patent/EP1377574B1/en not_active Expired - Lifetime
- 2002-02-21 US US10/467,568 patent/US6936622B2/en not_active Expired - Fee Related
- 2002-02-21 DE DE60202669T patent/DE60202669T2/de not_active Expired - Lifetime
- 2002-02-21 JP JP2002565990A patent/JP4248245B2/ja not_active Expired - Fee Related
- 2002-02-21 SI SI200230083T patent/SI1377574T1/xx unknown
- 2002-02-21 AT AT02722110T patent/ATE287403T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| DE60202669D1 (de) | 2005-02-24 |
| CA2438717C (en) | 2011-08-30 |
| EP1377574A1 (en) | 2004-01-07 |
| US20040097537A1 (en) | 2004-05-20 |
| US6936622B2 (en) | 2005-08-30 |
| JP2004526712A (ja) | 2004-09-02 |
| WO2002066476A1 (en) | 2002-08-29 |
| ES2236504T3 (es) | 2005-07-16 |
| DK1377574T3 (da) | 2005-04-25 |
| JP4248245B2 (ja) | 2009-04-02 |
| WO2002066476A9 (en) | 2003-10-30 |
| ATE287403T1 (de) | 2005-02-15 |
| DE60202669T2 (de) | 2005-09-15 |
| PT1377574E (pt) | 2005-05-31 |
| AU2002253045B2 (en) | 2007-07-12 |
| EP1377574B1 (en) | 2005-01-19 |
| CA2438717A1 (en) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1070056T1 (en) | Phthalazinone pde iii/iv inhibitors | |
| WO2004018431A3 (en) | Novel phenanthridines | |
| DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| MXPA02009567A (es) | Benzoilpirzoles y su uso como herbicidas. | |
| PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
| DE60311662D1 (en) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
| WO2004018465A3 (en) | Benzonaphthyridines with pde 3/4 inhibiting activity | |
| MXPA03008754A (es) | Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor. | |
| WO2004018451A8 (en) | Pyridazinone-derivatives as pde4 inhibitors | |
| MXPA02011411A (es) | Inhibidores de proteasa de serina. | |
| WO2002085906A3 (en) | Phthalazinones derivatives useful as pde4/7 inhibitors | |
| GB0030305D0 (en) | Compounds | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| GB9929552D0 (en) | Compounds | |
| MXPA03006224A (es) | Inhibidores de cruzipaina y otras proteasas de cisteina. | |
| MXPA03009750A (es) | Compuestos quimicos. | |
| AU2001264065A1 (en) | Serine protease inhibitors | |
| MY133969A (en) | Indoloquinazolinones | |
| SI1086096T1 (en) | Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors | |
| AU2001264081A1 (en) | Serine protease inhibitors | |
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| DK1377574T3 (da) | 6-phenylbenzonaphtyridiner | |
| MXPA04003755A (es) | Endoprotesis vasculares. | |
| MY128164A (en) | Compounds | |
| MXPA06003345A (es) | Derivados de aminopiridina como inhibidores de la no-sintasa inducible. |